92 related articles for article (PubMed ID: 2217278)
1. Circadian rhythms of tumor markers in breast cancer patients.
Touitou Y; Bailleul F; Lévi F; Bogdan A; Touitou C; Metzger G; Mechkouri M
Prog Clin Biol Res; 1990; 341A():59-66. PubMed ID: 2217278
[No Abstract] [Full Text] [Related]
2. [Tumor markers in the diagnosis and prognosis of breast cancer].
Seliuzhitskiĭ IV; Skvortsov SV; Lytsar BN; Khomenko LP
Klin Med (Mosk); 1993; 71(2):25-7. PubMed ID: 8046917
[TBL] [Abstract][Full Text] [Related]
3. [Tumor markers in metastatic breast carcinoma: correlations with clinical response].
Winer Y; Martini MC; Pastorino G; Moraglio L; Vallauri M; Brondi P; Brema F
J Nucl Med Allied Sci; 1990; 34(4 Suppl):127-30. PubMed ID: 2092107
[No Abstract] [Full Text] [Related]
4. The early detection of disseminated (metastasized) breast cancer by serial tumour marker measurements.
Jäger W
Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():133-9. PubMed ID: 8298443
[No Abstract] [Full Text] [Related]
5. Breast cancer and tumor markers.
Castellaro E; Francioni S; Pastore M
J Nucl Med Allied Sci; 1990; 34(4 Suppl):43-7. PubMed ID: 2092148
[No Abstract] [Full Text] [Related]
6. [Follow-up of tumor markers in evaluating the effectiveness of chemo- or hormone therapy of metastatic breast cancer].
Kürzl R; Kuss E
Geburtshilfe Frauenheilkd; 1993 Aug; 53(8):585-9. PubMed ID: 8375642
[No Abstract] [Full Text] [Related]
7. Power of chronobiologic pilots: a statistician's opinion.
Berry DA
Chronobiologia; 1993; 20(3-4):213-8. PubMed ID: 8131670
[No Abstract] [Full Text] [Related]
8. Serum CEA, CA 15-3, and MCA in breast cancer patients: a clinical evaluation.
Repetto L; Onetto M; Gardin G; Costanzi B; Giudici S; Vitiello E; Merlini L; Naso C; Zannini C; Paganuzzi M
Cancer Detect Prev; 1993; 17(3):411-5. PubMed ID: 8402728
[TBL] [Abstract][Full Text] [Related]
9. [A patient with pulmonary metastasis from breast cancer after surgery who responded to S-1].
Yoneyama K; Yamada A; Koshida Y; Toriumi F; Murayama T; Toeda H; Imazu Y; Motegi K; Akamatsu H; Ooyama R
Gan To Kagaku Ryoho; 2007 Jul; 34(7):1143-6. PubMed ID: 17637559
[TBL] [Abstract][Full Text] [Related]
10. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
[TBL] [Abstract][Full Text] [Related]
11. Kinetic use of tumor markers in the follow-up of patients operated for primary breast cancer.
Gion M; Fila G; Biasioli R; Vignati G; Mione R; Saracchini S; Rinaldi E; Testa E; Bruscagnin G
J Nucl Med Allied Sci; 1990; 34(4 Suppl):1-7. PubMed ID: 2092100
[No Abstract] [Full Text] [Related]
12. [Tumor markers in breast cancer].
Kurebayashi J
Gan To Kagaku Ryoho; 2004 Nov; 31(12):2077-81. PubMed ID: 15570944
[TBL] [Abstract][Full Text] [Related]
13. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
Chen C; Chen LQ; Yang GL; Li Y
Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322
[TBL] [Abstract][Full Text] [Related]
14. Mammary serum antigen (MSA), Ca 549, CA 15-3 and CEA in breast cancer preoperative sensitivity and correlation to prognostic factors.
Heinze T; Schürenkämper P; Minguillon C; Lichtenegger W
Anticancer Res; 1997; 17(4B):2953-4. PubMed ID: 9329573
[TBL] [Abstract][Full Text] [Related]
15. [Study for clinical usefulness of CEA, TPA, CA15-3 and BCA225 in breast cancer].
Kaneko Y; Imoto S; Kasakura S
Rinsho Byori; 1995 Jul; 43(7):696-702. PubMed ID: 7674542
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of four serological tumor markers for the detection of breast cancer.
Clinton SR; Beason KL; Bryant S; Johnson JT; Jackson M; Wilson C; Holifield K; Vincent C; Hall M
Biomed Sci Instrum; 2003; 39():408-14. PubMed ID: 12724928
[TBL] [Abstract][Full Text] [Related]
17. [The concentration of carcinoembryonic antigen and carbohydrate antigen Ca-19-9 in the blood serum in cancerous diseases of the gastrointestinal tract].
Mit'kov VV; Ogneva TV; Goriaĭnova II; Milanov S; Milkov V
Med Radiol (Mosk); 1989 Nov; 34(11):22-4. PubMed ID: 2586258
[TBL] [Abstract][Full Text] [Related]
18. [The clinico-diagnostic significance of tumor markers in malignant neoplasms].
Seliuzhitskiĭ IV; Skvortsov SV; Lytsar' BN
Voen Med Zh; 1993 Mar; (3):27-8. PubMed ID: 8498043
[No Abstract] [Full Text] [Related]
19. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
[TBL] [Abstract][Full Text] [Related]
20. [Adenocarcinoma of the bladder producing carcinoembryonic antigen and carbohydrate antigen 19-9: report of a case].
Iwaki H; Omatsu S; Konishi T; Moritani S
Hinyokika Kiyo; 1997 May; 43(5):355-8. PubMed ID: 9208321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]